ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Fmoc-N',N',N'-trimethyl-L-lysine chloride
C24H31ClN2O4
447 g/mol
Research Reagent

Fmoc-Lys(Me)3-OH chloride

CAS201004-29-7
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is an Fmoc-protected derivative of lysine featuring a trimethylammonium group at the N6 position, supplied as a chloride salt. It is primarily used in solid-phase peptide synthesis for incorporating a lysine residue with a permanently cationic side chain.

solid-phase peptide synthesisincorporation of cationic lysine analog into peptides

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-Lys(Me)3-OH chloride?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.74

Fmoc-N',N'-dimethyl-L-lysine hydrochloride

CAS252049-10-8

pharmaceutical intermediate

ReferenceSame Category

N-(2-Benzoyl-4-nitrophenyl)-2-bromoacetamide

CAS2011-70-3

research compound

ReferenceSame Category

4,6-dibromodibenzofuran

CAS201138-91-2

research compound

ReferenceSame Category

4-benzoyl-D-phenylalanine

CAS201466-03-7

research compound

ReferenceSame Category

(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine

CAS201594-84-5

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

[(5S)-5-carboxy-5-(9H-fluoren-9-ylmethoxycarbonylamino)pentyl]-trimethylazanium chloride

InChIKey

XUJRNPVABVHOAJ-FTBISJDPSA-N

SMILES

C[N+](C)(C)CCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13.[Cl-]

Synonyms (10)
  • Fmoc-Lys(Me)3-OH Cl
  • Fmoc-Lys(Me)3-OH chloride
  • Fmoc-Lys(Me)?-OH Chloride
  • Fmoc-Lys(Me3)-OH.nCl

Sourcing Fmoc-Lys(Me)3-OH chloride?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→